Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-01

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators conducted a bicentric prospective study to quantify the hemodynamic disturbances to the ostia of the renal arteries generated by the implantation EVAR with suprarenal fixation immediately postoperatively.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

NCT00753116

Kidney Failure, Chronic Renal Dialysis

COMPLETED PHASE1

Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease

NCT03293589

End-stage Renal Disease Critical Limb Ischemia

COMPLETED

Heparin Free Haemodialysis With Haemodialyzers "VIE" Versus "EVODIAL"

NCT01221337

Adult Chronic Haemodialysis Patients Since at Least 3 Months

COMPLETED NA

Cerebral Microembolism During Hemodialysis

NCT02021045

Complication of Dialysis Thrombus Due to Renal Dialysis Device, Implant, or Graft Cerebral Embolism

COMPLETED

SUPER-DIALYSIS-Study: Supera Stent Interventions in Juxta-anastomotic (re)Stenosis

NCT05232760

Stenosis of Arteriovenous Dialysis Fistula

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Aneurysm, Abdominal Endovascular Procedures Renal Artery Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

endovascular aneurysm repair (EVAR) arm

every patients are in the same arm and have EVAR with supra-renal fixation

Group Type EXPERIMENTAL

endovascular aneurysm repair (EVAR)

Intervention Type DEVICE

Patient will be enrolled when the decision of an endovascular procedure with supra renal fixation is required. Before the intervention, Duplex scan will be necessary to evaluate renal arteries ostia. This exam will be realised in the month after the intervention and one year later.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endovascular aneurysm repair (EVAR)

Patient will be enrolled when the decision of an endovascular procedure with supra renal fixation is required. Before the intervention, Duplex scan will be necessary to evaluate renal arteries ostia. This exam will be realised in the month after the intervention and one year later.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective EVAR with supra renal fixation
* women who have been postmenopausal for at least 24 months or are surgically sterilized, or for women of childbearing potential, use of an effective method of contraception
* consent to participate
* Affiliation to a French social security

Exclusion Criteria

* stenosis of at least one renal artery
* dialysis
* rupture of abdominal aortic aneurysm
* renal stenting during the procedure
* fenestrated EVAR
* legal incapacity or limited legal capacity
* subject being in the exclusion period of another study
* pregnant woman

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No